Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'

S. H. Hanemaaijer; I. C. Kok; R. S. N. Fehrmann; B. van der Vegt; J. A. Gietema; B. E. C. Plaat; M. A. T. M. Vugt; M. R. Vergeer; J. Voortman; C. R. Leemans; J. Buter; J. A. Langendijk; S. F. Oosting

Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'

S. H. Hanemaaijer, I. C. Kok, R. S. N. Fehrmann, B. van der Vegt, J. A. Gietema, B. E. C. Plaat, M. A. T. M. Vugt, M. R. Vergeer, J. Voortman, C. R. Leemans, J. Buter, J. A. Langendijk, S. F. Oosting

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	28
Publication status	Published - Sept-2017
Event	42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8-Sept-2017 → 12-Sept-2017

Access to Document

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2017-Congress/Comparison-of-carboplatin-with-5-fluorouracil-carbo-5FU-versus-cisplatin-as-concomitant-chemoradiotherapy-CRT-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-LA-HNSCC

Handle.net

Persistent link

Cite this

Hanemaaijer, S. H., Kok, I. C., Fehrmann, R. S. N., van der Vegt, B., Gietema, J. A., Plaat, B. E. C., Vugt, M. A. T. M., Vergeer, M. R., Voortman, J., Leemans, C. R., Buter, J., Langendijk, J. A., & Oosting, S. F. (2017). Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'. Annals of Oncology, 28. http://oncologypro.esmo.org/Meeting-Resources/ESMO-2017-Congress/Comparison-of-carboplatin-with-5-fluorouracil-carbo-5FU-versus-cisplatin-as-concomitant-chemoradiotherapy-CRT-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-LA-HNSCC

@article{828730ba2d094d1d97758bce99943b03,

title = "Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'",

author = "Hanemaaijer, {S. H.} and Kok, {I. C.} and Fehrmann, {R. S. N.} and {van der Vegt}, B. and Gietema, {J. A.} and Plaat, {B. E. C.} and Vugt, {M. A. T. M.} and Vergeer, {M. R.} and J. Voortman and Leemans, {C. R.} and J. Buter and Langendijk, {J. A.} and Oosting, {S. F.}",

year = "2017",

month = sep,

language = "English",

volume = "28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "42nd European-Society-for-Medical-Oncology Congress (ESMO) ; Conference date: 08-09-2017 Through 12-09-2017",

}

Hanemaaijer, SH, Kok, IC, Fehrmann, RSN , van der Vegt, B , Gietema, JA , Plaat, BEC , Vugt, MATM, Vergeer, MR, Voortman, J, Leemans, CR, Buter, J, Langendijk, JA & Oosting, SF 2017, 'Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'', Annals of Oncology, vol. 28. <http://oncologypro.esmo.org/Meeting-Resources/ESMO-2017-Congress/Comparison-of-carboplatin-with-5-fluorouracil-carbo-5FU-versus-cisplatin-as-concomitant-chemoradiotherapy-CRT-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-LA-HNSCC>

TY - JOUR

T1 - Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'

AU - Hanemaaijer, S. H.

AU - Kok, I. C.

AU - Fehrmann, R. S. N.

AU - van der Vegt, B.

AU - Gietema, J. A.

AU - Plaat, B. E. C.

AU - Vugt, M. A. T. M.

AU - Vergeer, M. R.

AU - Voortman, J.

AU - Leemans, C. R.

AU - Buter, J.

AU - Langendijk, J. A.

AU - Oosting, S. F.

PY - 2017/9

Y1 - 2017/9

M3 - Meeting Abstract

SN - 0923-7534

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

T2 - 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Y2 - 8 September 2017 through 12 September 2017

ER -